UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

Projection of Target Drug Particle Size in Oral Formulations Using the Refined Developability Classification System (rDCS)

Pharmaceutics, 2023-07, Vol.15 (7), p.1909

2023

Volltextzugriff (PDF)

A Stratified Analysis of Supersaturation and Precipitation Effects Based on the Refined Developability Classification System (rDCS)

Journal of pharmaceutical sciences, 2024-06

2024

Volltextzugriff (PDF)

Characterization of 2-(2,6-dichloro-benzyl)-thiazolo[5,4- d]pyrimidin-7-yl]-(4-trifluoromethyl-phenyl)-amine (JNJ-39729209) as a novel TRPV1 antagonist

European journal of pharmacology, 2011-08, Vol.663 (1), p.40-50

2011

Volltextzugriff (PDF)

A Dipolar Cycloaddition Reaction To Access 6‑Methyl-4,5,6,7-tetrahydro‑1H‑[1,2,3]triazolo[4,5‑c]pyridines Enables the Discovery Synthesis and Preclinical Profiling of a P2X7 Antagonist Clinical Candidate

Journal of medicinal chemistry, 2018-01, Vol.61 (1), p.207-223

2018

Volltextzugriff (PDF)

Design, Synthesis, and Preclinical Evaluation of 3‑Methyl-6-(5-thiophenyl)-1,3-dihydro-imidazo[4,5‑b]pyridin-2-ones as Selective GluN2B Negative Allosteric Modulators for the Treatment of Mood Disorders

Journal of medicinal chemistry, 2020-09, Vol.63 (17), p.9181-9196

2020

Volltextzugriff (PDF)

Identification of (R)‑(2-Chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyridin-2-yl)-4-methyl-6,7-dihydro‑1H‑imidazo[4,5‑c]pyridin-5(4H)‑yl)methanone (JNJ 54166060), a Small Molecule Antagonist of the P2X7 receptor

Journal of medicinal chemistry, 2016-09, Vol.59 (18), p.8535-8548

2016

Volltextzugriff (PDF)

Discovery of JNJ-64264681: A Potent and Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase

Journal of medicinal chemistry, 2022-11, Vol.65 (21), p.14326-14336

2022

Volltextzugriff (PDF)

A Dipolar Cycloaddition Reaction To Access 6-Methyl-4,5,6,7-tetrahydro-1 H -[1,2,3]triazolo[4,5- c ]pyridines Enables the Discovery Synthesis and Preclinical Profiling of a P2X7 Antagonist Clinical Candidate

Journal of medicinal chemistry, 2018-01, Vol.61 (1), p.207-223

2018

Volltextzugriff (PDF)

Comparison of aqueous solubility estimation from AQUAFAC and the GSE

International journal of pharmaceutics, 2008-08, Vol.360 (1), p.122-147

2008

Volltextzugriff (PDF)

Identification of ( R )-(2-Chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyridin-2-yl)-4-methyl-6,7-dihydro-1 H -imidazo[4,5- c ]pyridin-5(4 H )-yl)methanone (JNJ 54166060), a Small Molecule Antagonist of the P2X7 receptor

Journal of medicinal chemistry, 2016-09, Vol.59 (18), p.8535-8548

2016

Volltextzugriff (PDF)

Accounting for the Effects of Moderately Increased Pressure on the Energetics of Melting and Solubility in Metered Dose Inhalers

Drug development and industrial pharmacy, 2008-01, Vol.34 (9), p.930-935

2008

Volltextzugriff (PDF)

Simplified Estimation of the Octanol−Air Partition Coefficient

Industrial & engineering chemistry research, 2007-03, Vol.46 (7), p.2220-2223

2007

Volltextzugriff (PDF)

Solubility prediction in octanol: A technical note

AAPS PharmSciTech, 2006-03, Vol.7 (1), p.E184

2006

Volltextzugriff (PDF)

Accounting for the Effects of Moderately Increased Pressure on the Energetics of Melting and Solubility in Metered Dose Inhalers: Innovative Inhalation Technologies

Drug development and industrial pharmacy, 2008, Vol.34 (9), p.930-935

2008

Volltextzugriff (PDF)

Estimating Pure-Component Vapor Pressures of Complex Organic Molecules: Part II

Industrial & engineering chemistry research, 2006-12, Vol.45 (25), p.8744-8747

2006

Volltextzugriff (PDF)

The besylate salt of carbendazim: 2-(methoxycarbonylamino)benzimidazolium benzenesulfonate

Acta crystallographica. Section E, Structure reports online, 2006-10, Vol.62 (10), p.o4403-o4404

2006

Volltextzugriff (PDF)

Solubility prediction in octanol: a technical note

AAPS PharmSciTech, 2006-03, Vol.7 (1), p.E26-E191

2006

Volltextzugriff (PDF)

Formulation and in vivo evaluation of chlorpropham (CIPC) oral formulations

Journal of pharmaceutical sciences, 2008-12, Vol.97 (12), p.5222-5228

2008

Volltextzugriff (PDF)

Pre-clinical characterization of aryloxypyridine amides as histamine H sub(3) receptor antagonists: Identification of candidates for clinical development

Bioorganic & medicinal chemistry letters, 2010-07, Vol.20 (14), p.4210-4214

2010

Volltextzugriff (PDF)

The napsylate salt of carbendazim: 2‐(methoxycarbonylamino)benzimidazolium naphthalene‐1‐sulfonate

Acta crystallographica. Section E, Structure reports online, 2006-11, Vol.62 (11), p.o5172-o5173

2006

Volltextzugriff (PDF)

Estimations of octanol solubility, vapor pressure, octanol-air partition coefficient, and air-water partition coefficient

Sepassi, Kia

2007

Volltextzugriff (PDF)

Estimations of octanol solubility, vapor pressure, octanol-air partition coefficient, and air-water partition coefficient

Sepassi, Kia

2007

Volltextzugriff (PDF)

Pre-clinical characterization of aryloxypyridine amides as histamine H3 receptor antagonists: Identification of candidates for clinical development

Bioorganic & medicinal chemistry letters, 2010-07, Vol.20 (14), p.4210-4214

2010

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(24)
Dissertationen
(2)

Sprache

Englisch
(26)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(15)
Life Sciences & Biomedicine
(11)
Pharmacology & Pharmacy
(11)
Animals
(6)
Chemistry, Medicinal
(6)
Rats
(6)
Biological And Medical Sciences
(5)
Medical Sciences
(5)
Pharmacology. Drug Treatments
(5)
Solubility
(5)
Dogs
(3)
General Pharmacology
(3)
Humans
(3)
Mice
(3)
Pharmaceutical Technology. Pharmaceutical Industry
(3)
Physical Sciences
(3)
Pyridines - Chemistry
(3)
Administration, Oral
(2)
Applied Sciences
(2)
Chemical Engineering
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Projection of Target Drug Particle Size in Oral Formulations Using the Refined Developability Classification System (rDCS)

Pharmacological characterization of 1-(5-chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic acid (JNJ-42041935), a potent and selective hypoxia-inducible factor prolyl hydroxylase inhibitor

A Stratified Analysis of Supersaturation and Precipitation Effects Based on the Refined Developability Classification System (rDCS)

Characterization of 2-(2,6-dichloro-benzyl)-thiazolo[5,4- d]pyrimidin-7-yl]-(4-trifluoromethyl-phenyl)-amine (JNJ-39729209) as a novel TRPV1 antagonist

A Dipolar Cycloaddition Reaction To Access 6‑Methyl-4,5,6,7-tetrahydro‑1H‑[1,2,3]triazolo[4,5‑c]pyridines Enables the Discovery Synthesis and Preclinical Profiling of a P2X7 Antagonist Clinical Candidate

Design, Synthesis, and Preclinical Evaluation of 3‑Methyl-6-(5-thiophenyl)-1,3-dihydro-imidazo[4,5‑b]pyridin-2-ones as Selective GluN2B Negative Allosteric Modulators for the Treatment of Mood Disorders

Identification of (R)‑(2-Chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyridin-2-yl)-4-methyl-6,7-dihydro‑1H‑imidazo[4,5‑c]pyridin-5(4H)‑yl)methanone (JNJ 54166060), a Small Molecule Antagonist of the P2X7 receptor

Discovery of JNJ-64264681: A Potent and Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase

A Dipolar Cycloaddition Reaction To Access 6-Methyl-4,5,6,7-tetrahydro-1 H -[1,2,3]triazolo[4,5- c ]pyridines Enables the Discovery Synthesis and Preclinical Profiling of a P2X7 Antagonist Clinical Candidate

Comparison of aqueous solubility estimation from AQUAFAC and the GSE

Identification of ( R )-(2-Chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyridin-2-yl)-4-methyl-6,7-dihydro-1 H -imidazo[4,5- c ]pyridin-5(4 H )-yl)methanone (JNJ 54166060), a Small Molecule Antagonist of the P2X7 receptor

Accounting for the Effects of Moderately Increased Pressure on the Energetics of Melting and Solubility in Metered Dose Inhalers

Simplified Estimation of the Octanol−Air Partition Coefficient

Solubility prediction in octanol: A technical note

Accounting for the Effects of Moderately Increased Pressure on the Energetics of Melting and Solubility in Metered Dose Inhalers: Innovative Inhalation Technologies

Estimating Pure-Component Vapor Pressures of Complex Organic Molecules: Part II

Pharmacological Characterization of 1-(5-Chloro-6-(trifluoromethoxy)-1 H -benzoimidazol-2-yl)-1 H -pyrazole-4-carboxylic Acid (JNJ-42041935), a Potent and Selective Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor

The besylate salt of carbendazim: 2-(methoxycarbonylamino)benzimidazolium benzenesulfonate

Solubility prediction in octanol: a technical note

Formulation and in vivo evaluation of chlorpropham (CIPC) oral formulations

Pre-clinical characterization of aryloxypyridine amides as histamine H sub(3) receptor antagonists: Identification of candidates for clinical development

The napsylate salt of carbendazim: 2‐(methoxycarbonylamino)benzimidazolium naphthalene‐1‐sulfonate

Estimations of octanol solubility, vapor pressure, octanol-air partition coefficient, and air-water partition coefficient

Estimations of octanol solubility, vapor pressure, octanol-air partition coefficient, and air-water partition coefficient

Pre-clinical characterization of aryloxypyridine amides as histamine H3 receptor antagonists: Identification of candidates for clinical development

Suchergebnisse filtern